Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors
In a step toward fighting solid tumors in children and young adults, Penn State College of Medicine, the Beat Childhood Cancer Research Consortium and Four Diamonds, along with Senhwa Biosciences, Inc. are launching a pioneering clinical[...]
Q&A: Finding novel therapies for childhood cancer
Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with[...]
FDA approves pediatric neuroblastoma drug based on Penn State professor’s work
Giselle Saulnier Sholler, professor of pediatrics and of pharmacology, reflects on 20 years working to change cancer outcomes for children HERSHEY, Pa. — In 2003, the first year of her[...]
US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer
LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk[...]
Penn State Health recruits leading researcher to fight pediatric cancer
Cris Collingwood//August 2, 2023 An internationally known physician-scientist and her research consortium have joined Penn State Health to continue efforts to eradicate pediatric cancer. Penn State Health and Penn State College of Medicine[...]
The Power of Will
Will Lacey was just a baby when doctors diagnosed a rare form of cancer and told his family there was only one end. Nobody then could imagine the journey ahead,[...]
Michigan Child Trials Target Genetic Roots of Cancers
Thank you Detroit News for featuring a story about the work we are doing. It wouldn’t be possible without the support of Dell, TGen Foundation and our generous community. Together,[...]
$1,100,000 for Beat Childhood Cancer Research!
On December 24, 2014 the Grand Rapids community surpassed the Million Dollar Challenge by raising $1,100,000 for NMTRC research! This donation was then matched by a generous Beat NB donor[...]
Endowment Gift Establishes Haworth Family Pediatric Oncology Innovative Therapeutics Clinic at Helen Devos Children’s Hospital
Children fighting cancer have new hope thanks to an endowment gift from Dick and Ethie Haworth to the Helen DeVos Children’s Hospital Foundation. Their major gift establishes the Haworth Family[...]
Research: Beat Childhood Cancer
The Beat Childhood Cancer Research Consortium is a group of 54+ universities and children's hospitals
We are so lucky to have such an amazing team! 🍀
Last weekend was Penn State THON™, a dance marathon led by students at The Pennsylvania State University. This marathon dance event lasts 46 hours, and students must remain on their feet throughout the entire event! It is truly amazing to see this community come together to support pediatric cancer patients and the research we need to create change.
Our chair, Dr. Sholler, was able to attend THON this year and was truly amazed by the compassion and hope shown throughout the weekend. We are honored to work with Four Diamonds and look forward to what we can accomplish together!
Photos from Caroline's PEACH Foundation's post
On International Childhood Cancer Day, we honor the strength of young heroes and the tireless dedication of those who fight alongside them. 💛
We’re excited to announce a new chapter in the fight against childhood cancer! Dr. Jaume Mora, Scientific Director of the Oncology and Hematology Department at SJD Barcelona Children's Hospital, will lead the first international expansion of the Research Consortium outside of North America.
This spring, the Barcelona location will open its doors, bringing us one step closer to global collaboration and breakthroughs in childhood cancer research.
Read more about Dr. Mora's work and this exciting milestone here: www.sjdhospitalbarcelona.org/en/specialists/jaume-mora-graupera
#beatchildhoodcancer #beatchildhoodcancerfoundation #beatchildhoodcancerresearch #internationalchildhoodcancerday #childhoodcancer #childhoodcancerresearch #nonprofit #nonprofitorganization
We were honored to have contributed our review of DFMO in a Special Issue of The Journal of Clinical Medicine on High-Risk Neuroblastoma: New Clinical Insights and Challenges published last week!
This review article was titled "Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy" written by Dr. Schramm, Dr. Sholler and 3 of our BCC summer interns.
doi.org/10.3390/jcm14041068
